Abstract
Activation of free radical oxidation and inhibition of antioxidant activity in mouse myocardium after long-term dipyridamole treatment were demonstrated using chemiluminescent techniques. At the same time, dipyridamole 10-fold inhibited free radical oxidation and slightly increased antioxidant activity in the plasma. Dipyridamole-induced platelet disaggregation was accompanied by an increase in platelet count.
Similar content being viewed by others
REFERENCES
G. E. Arkad'eva, Arkh. Anat., 100, No. 4, 74-81 (1991).
I. N. Ivasenko, Yu. A. Blyudzin, D. N. Chernyakova, et al., Byull. Eksp. Biol. Med., 114, No. 12, 611-613 (1992).
V. M. Prokopenko, A. V. Arutyunyan, T. U. Kuz'minykh, et al., Vopr. Med. Khimii, 41, No. 3, 53-57 (1995).
N. Borchers and C. Hohoff, Prostaglandin. Leukot. Essent. Fatty Acids, 57, No. 1, 77-84 (1997).
C. Cecconi, S. Curello, and O. Visioli, Eur. Heart J., 19,Suppl. B, B2-B11 (1998).
G. Feuerstein, T. L. Yue, X. Ma, and R. R. Ruffolo, Progr. Cardiovasc. Dis., 48, No. 1, Suppl. 1, 17-24 (1998).
S. Heinzl, Med. Monatsschr. Pharm., 19, No. 11, 319 (1996).
Li Xiao-Dan and Li Jin, Acta Physiol. Sin., 51, No. 2, 234-239 (1999).
C. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, J. Biol. Chem., 193, 265-275 (1951).
P. Pavini, B. Angelin, and M. Rudling, Arteriosclerosis Thromb. Vasc. Biol., 19, No. 4, 832-839 (1999).
R. R. Jr. Ruffolo and G. Z. Feurstein, J. Cardiovasc. Pharmacol., 32,Suppl. P, 22-30 (1998).
B. I. Strehler and C. S. Soup, Arch. Biochem. Biophys., 47, 8-15 (1953).
Z. E. Winters, W. M. Ongkeko, A. L. Harris, et al., Oncogene, 17, No. 6, 673-684 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ivasenko, I.N., Shlyakhto, E.V. Free Radical Oxidation and Antioxidant Activity in Blood Plasma and Myocardium during Long-Term Dipyridamole Treatment. Bulletin of Experimental Biology and Medicine 131, 538–540 (2001). https://doi.org/10.1023/A:1012342300406
Issue Date:
DOI: https://doi.org/10.1023/A:1012342300406